5FXJ
GluN1b-GluN2B NMDA receptor structure-Class X
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, C (A, C) | GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1 | polymer | 846 | 95220.7 | 2 | UniProt (P35439) Pfam (PF01094) Pfam (PF10613) Pfam (PF00060) | RATTUS NORVEGICUS (NORWAY RAT) | GLUN1, GLUTAMATE NMDA RECEPTOR SUBUNIT ZETA-1, N-METHYL-D-A SPARTATE RECEPTOR SUBUNIT NR1, NMD-R1, GLUN1 |
| 2 | B, D (B, D) | GLUTAMATE RECEPTOR IONOTROPIC, NMDA 2B | polymer | 827 | 92931.1 | 2 | UniProt (Q00960) Pfam (PF01094) Pfam (PF10613) Pfam (PF00060) | RATTUS NORVEGICUS (NORWAY RAT) | GLUN2B, GLUTAMATE NMDA RECEPTOR SUBUNIT EPSILON-2, N-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2B, NMDAR2B, NR2B, GLUN2B |
Sequence modifications
A, C: 23 - 868 (UniProt: P35439)
B, D: 27 - 852 (UniProt: Q00960)
| PDB | External Database | Details |
|---|---|---|
| Gln 61 | Asn 61 | engineered mutation |
| Asp 260 | Asn 239 | engineered mutation |
| Gln 371 | Asn 350 | engineered mutation |
| Gln 492 | Asn 471 | engineered mutation |
| Gln 512 | Asn 491 | engineered mutation |
| Gln 615 | Glu 594 | engineered mutation |
| Ser 616 | Glu 595 | engineered mutation |
| Ser 618 | Glu 597 | engineered mutation |
| Thr 619 | Glu 598 | engineered mutation |
| Gln 792 | Asn 771 | engineered mutation |
| Cys 831 | Phe 810 | engineered mutation |
| Asn 865 | Arg 844 | engineered mutation |
| Gly 866 | Arg 845 | engineered mutation |
| Ala 867 | Lys 846 | engineered mutation |
| PDB | External Database | Details |
|---|---|---|
| Gly 26 | - | expression tag |
| Asp 348 | Asn 348 | engineered mutation |
| Cys 557 | Asp 557 | engineered mutation |
| Ser 588 | Cys 588 | engineered mutation |
| Ser 838 | Cys 838 | engineered mutation |
| Ser 849 | Cys 849 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 4 |
| Total formula weight | 376303.6 | |
| All* | Total formula weight | 376303.6 |






